Insights / October 16, 2019 / by beaconlbs

Featured Lab-Of-Choice: GeneDx

BeaconLBS has invited the Labs-of-Choice™ to provide some more information about themselves for a blog series featuring each of the Labs-of-Choice. The following content was provided by the featured lab, GeneDx.

Company Description: Rare Genetics Laboratory

GeneDx was founded in 2000 by two scientists from the National Institutes of Health (NIH) to diagnose patients with rare disorders and assist clinicians responsible for treating these patients. GeneDx has become a global industry leader in genetics and genomics, having provided testing to patients and their families in over 55 countries.

Led by its clinical genomics program, and a comprehensive genetic testing menu, GeneDx offers genetic testing for hereditary cancers, cardiac, mitochondrial, rare and neurological disorders, prenatal diagnostics, and targeted variant testing. To date, GeneDx has performed over 150,000 exomes. www.genedx.com

You Might Also Like:

Insights / March 10, 2019 / by beaconlbs

MagnaCare Announces Collaboration with BeaconLBS to Help Physicians Select Laboratory Tests that Can Improve Patient Care and Reduce Costs

MagnaCare, a leader in health plan management services, announced today that it has entered into an agreement with BeaconLBS.

Insights / February 20, 2019 / by beaconlbs

The BeaconLBS Evidence-Based Process for Managing Lab Tests

BeaconLBS works with our health plan, employer and accountable care organization (ACO) partners to use evidence-based policies and guide lab test benefit management. Read about our four steps below.